Stock listing
Munich:MOL0 Moleculin Biotech, Inc. Aktie
German listing (Munich) of Moleculin Biotech, Inc. · home listing NASDAQ:MBRX
Follow Moleculin Biotech, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MBRX
$7.90 USD -0.82 (-9.4%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MBRX
- Day range
- $7.90 – $9.00 USDOct 30, 2026
- Volume
- 31,717 sharesOct 30, 2026
- Market cap
- $8.05M USDAt the close on Oct 30, 2026 · price × 1.02M shares outstanding
- 52-week range
- $3.23 – $315.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $107,286 USDMedian day 2,062 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MBRX · Home | $7.90 USD | -0.82 (-9.4%) | 31,717 | $8.80 | $9.00 | $7.90 | $8.72 | Close on Oct 30, 2026 |
| LSE:0K2H | $0.266 USD | -0.027 (-9.3%) | 9,568 | $0.292 | $0.312 | $0.233 | $0.293 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MBRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.90 | -0.82 | -9.4% | $8.80 | $9.00 | $7.90 | 31,717 | |
| $8.72 | -0.025 | -0.3% | $8.70 | $8.84 | $8.079 | 33,993 | |
| $8.745 | -0.52 | -5.6% | $9.41 | $10.24 | $8.10 | 101,857 | |
| $9.265 | +2.18 | +30.8% | $7.18 | $9.719 | $7.17 | 188,858 | |
| $7.085 | +0.585 | +9.0% | $6.59 | $7.25 | $6.50 | 25,459 | |
| $6.50 | +0.61 | +10.4% | $6.05 | $6.59 | $5.648 | 27,667 | |
| $5.89 | -0.42 | -6.7% | $6.13 | $6.164 | $5.46 | 59,128 | |
| $6.31 | +0.12 | +1.9% | $6.00 | $6.58 | $6.00 | 41,996 | |
| $6.19 | +0.89 | +16.8% | $5.74 | $6.403 | $5.24 | 131,770 | |
| $5.30 | -0.308 | -5.5% | $5.60 | $5.60 | $4.42 | 2,666 | |
| $5.608 | -1.794 | -24.2% | $6.20 | $6.60 | $5.60 | 2,971 | |
| $7.402 | -0.818 | -10.0% | $8.40 | $8.52 | $7.402 | 840 | |
| $8.22 | -0.484 | -5.6% | $8.798 | $8.798 | $8.192 | 687 | |
| $8.704 | +0.426 | +5.1% | $8.48 | $8.722 | $8.204 | 459 | |
| $8.278 | -0.562 | -6.4% | $9.00 | $9.062 | $8.20 | 435 | |
| $8.84 | +0.36 | +4.2% | $8.398 | $9.128 | $8.254 | 856 | |
| $8.48 | -0.298 | -3.4% | $8.742 | $8.83 | $8.214 | 670 | |
| $8.778 | -0.132 | -1.5% | $9.158 | $9.164 | $8.62 | 1,084 | |
| $8.91 | -0.622 | -6.5% | $9.756 | $9.80 | $8.80 | 1,767 | |
| $9.532 | -0.204 | -2.1% | $9.80 | $9.804 | $9.236 | 1,191 | |
| $9.736 | -0.34 | -3.4% | $10.20 | $10.30 | $9.43 | 1,056 | |
| $10.08 | +0.068 | +0.7% | $10.10 | $10.38 | $10.00 | 843 | |
| $10.01 | -0.52 | -4.9% | $10.82 | $11.00 | $9.84 | 1,800 | |
| $10.53 | -0.852 | -7.5% | $11.46 | $11.60 | $10.40 | 4,162 | |
| $11.38 | -0.652 | -5.4% | $12.00 | $12.00 | $10.80 | 1,564 | |
| $12.03 | +0.694 | +6.1% | $11.02 | $13.39 | $10.60 | 6,538 | |
| $11.34 | +0.78 | +7.4% | $10.40 | $11.40 | $10.20 | 1,345 | |
| $10.56 | -0.742 | -6.6% | $11.60 | $12.51 | $10.10 | 4,560 | |
| $11.30 | +0.896 | +8.6% | $10.80 | $13.60 | $10.00 | 14,698 | |
| $10.40 | -5.058 | -32.7% | $14.44 | $14.66 | $10.01 | 10,310 | |
| $15.46 | -0.138 | -0.9% | $15.61 | $15.98 | $15.00 | 1,166 | |
| $15.60 | +0.80 | +5.4% | $15.20 | $15.93 | $14.80 | 762 | |
| $14.80 | -0.232 | -1.5% | $15.20 | $15.64 | $14.60 | 685 | |
| $15.03 | -0.472 | -3.0% | $16.20 | $16.35 | $15.01 | 1,189 | |
| $15.50 | +1.204 | +8.4% | $15.00 | $16.40 | $15.00 | 1,798 | |
| $14.30 | -2.298 | -13.8% | $17.00 | $17.98 | $14.20 | 4,830 | |
| $16.60 | +1.298 | +8.5% | $15.76 | $16.60 | $15.47 | 1,334 | |
| $15.30 | +0.298 | +2.0% | $15.42 | $16.05 | $15.01 | 952 | |
| $15.00 | +0.804 | +5.7% | $14.70 | $16.00 | $14.48 | 1,842 | |
| $14.20 | +0.688 | +5.1% | $13.80 | $14.75 | $13.60 | 1,939 | |
| $13.51 | -0.37 | -2.7% | $14.00 | $14.60 | $13.02 | 1,083 | |
| $13.88 | +0.88 | +6.8% | $13.10 | $14.00 | $12.77 | 875 | |
| $13.00 | +0.106 | +0.8% | $12.80 | $13.10 | $12.40 | 658 | |
| $12.89 | -0.104 | -0.8% | $12.80 | $13.44 | $12.40 | 753 | |
| $13.00 | -0.776 | -5.6% | $13.80 | $14.18 | $12.80 | 1,536 | |
| $13.77 | +1.774 | +14.8% | $12.40 | $14.23 | $12.19 | 3,725 | |
| $12.00 | -0.22 | -1.8% | $12.68 | $13.10 | $11.80 | 1,159 | |
| $12.22 | +0.034 | +0.3% | $12.00 | $13.38 | $11.96 | 2,258 | |
| $12.19 | +0.326 | +2.7% | $12.20 | $12.40 | $11.29 | 1,045 | |
| $11.86 | +0.048 | +0.4% | $11.75 | $12.60 | $11.20 | 735 | |
| $11.81 | +0.372 | +3.3% | $11.60 | $12.72 | $11.00 | 2,674 | |
| $11.44 | -0.762 | -6.2% | $12.11 | $12.20 | $11.40 | 1,658 | |
| $12.20 | +0.062 | +0.5% | $12.00 | $13.20 | $11.80 | 1,645 | |
| $12.14 | -0.104 | -0.8% | $12.76 | $13.30 | $11.20 | 2,185 | |
| $12.24 | +0.818 | +7.2% | $12.00 | $12.80 | $11.60 | 3,862 | |
| $11.43 | +0.982 | +9.4% | $10.71 | $11.68 | $10.50 | 3,331 | |
| $10.44 | +1.544 | +17.3% | $8.996 | $10.68 | $8.60 | 3,183 | |
| $8.90 | +0.292 | +3.4% | $8.60 | $9.20 | $8.20 | 2,487 | |
| $8.608 | +0.418 | +5.1% | $8.396 | $9.20 | $8.03 | 3,905 | |
| $8.19 | +0.49 | +6.4% | $7.72 | $8.30 | $7.61 | 2,503 | |
| $7.70 | -0.10 | -1.3% | $8.00 | $8.36 | $6.908 | 5,403 | |
| $7.80 | -0.388 | -4.7% | $8.20 | $8.78 | $7.602 | 3,942 | |
| $8.188 | -0.312 | -3.7% | $8.78 | $8.78 | $7.60 | 5,699 | |
| $8.50 | +0.50 | +6.3% | $7.40 | $9.00 | $3.228 | 21,906 | |
| $8.00 | -12.40 | -60.8% | $17.60 | $21.38 | $6.246 | 48,279 | |
| $20.40 | -6.80 | -25.0% | $26.80 | $26.80 | $20.20 | 3,966 |
- Ticker
- Munich:MOL0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 30, 2026
Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
Latest deck · Oct 16, 2026
Investor Presentation (October 2026)
Investor deck · 55 slides
Calls
Replays
Moleculin Biotech (NASDAQ:MBRX) Q1 2025 Earnings Call
Wed, May 14, 2025 · 8:30 AM ET
Watch TranscriptMoleculin Biotech (NASDAQ:MBRX) Q4 2024 Earnings Call
Mon, Mar 24, 2025 · 8:30 AM ET
Watch TranscriptMoleculin Biotech (NASDAQ:MBRX) Q3 2024 Earnings Call
Mon, Nov 11, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
Oct 30, 2026
Closed $7.90 (-9.4%) on Oct 30, 2026
Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial
Oct 20, 2026
Closed $6.19 (+16.8%) on Oct 20, 2026
Moleculin Announces Reverse Stock Split
Oct 16, 2026
Closed $5.61 (-24.2%) on Oct 16, 2026
Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
Oct 7, 2026
Closed $8.78 (-1.5%) on Oct 7, 2026
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
Sep 29, 2026
Closed $10.53 (-7.5%) on Sep 29, 2026
Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
Sep 28, 2026
Closed $11.38 (-5.4%) on Sep 28, 2026
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
Sep 25, 2026
Closed $12.03 (+6.1%) on Sep 25, 2026
Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
Sep 23, 2026
Closed $10.56 (-6.6%) on Sep 23, 2026
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
Sep 11, 2026
Closed $14.30 (-13.8%) on Sep 11, 2026
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
Aug 27, 2026
Closed $13.77 (+14.8%) on Aug 27, 2026
Financings
Not stated
Aug 14, 2026
Closed: US$9.3M raised
Use of proceeds: To support planned operations into the first quarter of 2027
Decks
Investor Presentation (October 2026)
Investor deck · 55 slides · Oct 16, 2026
Investor Presentation (August 2026)
Investor deck · 59 slides · Aug 31, 2026
Investor Presentation (June 2026)
Investor deck · 57 slides · Jun 30, 2026
Investor Presentation (May 2026)
Investor deck · 48 slides · May 26, 2026
Moleculin Biotech, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 44 in the last 12 months · 245 in all · newest Oct 30, 2026 · oldest 2019
- Calls
- 10 calls with a replay · 10 with a transcript · latest May 14, 2025
- Decks
- 53 decks · latest Oct 16, 2026
Where Moleculin Biotech, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MBRX · Home listing | NASDAQ | United States | USD |
| BOATS:MBRX | BOATS | United States | USD |
| LSE:0K2H | LSE | United Kingdom | USD |
| gettex:MOL0 | gettex | Germany | EUR |
| Frankfurt:MOL0 | Frankfurt | Germany | EUR |
| Munich:MOL0 · This page | Munich | Germany | EUR |
| Lang & Schwarz:A41SET | Lang & Schwarz | Germany | EUR |
Log in to ask 6ix AI your own questions about Moleculin Biotech, Inc.